Literature DB >> 27515029

Therapies for Parkinson's diseases: alternatives to current pharmacological interventions.

Song Li1, Jie Dong1, Cheng Cheng1, Weidong Le2,3.   

Abstract

Parkinson's disease (PD) is the second most common neurodegenerative disorder caused by the selective and progressive loss of dopaminergic neurons in the substantia nigra pars compacta. Although PD has been heavily researched, the precise etiology and pathogenesis for PD are still inconclusive. Consequently, current pharmacological treatments for PD are largely symptomatic rather than preventive and there is still no cure for this disease nowadays. Moreover, nonmotor symptoms caused by intrinsic PD pathology or side effects induced by currently used pharmacological interventions are gaining increasing attention and urgently need to be treated due to their influence on quality of life. As ancient traditional healing systems, Tai Chi, Yoga, acupuncture and natural products have long been considered as complementary or alternative therapeutic options for PD. Recently, several newly developed non-pharmacological therapeutic strategies, including deep brain stimulation, repetitive transcranial magnetic stimulation, near-infrared light, gene therapy and cell replacement therapy, have also been suggested to give benefits to relieve parkinsonian symptoms. This review will summarize and update the therapeutic potential and the most recent research progresses of these traditional and modern therapeutic options and highlight their clinical meaning for the therapy of not only PD but also other neurodegenerative diseases.

Entities:  

Keywords:  Cell transplantation; Complementary and alternative therapy; Deep brain stimulation; Gene therapy; Herbal medicine; Parkinson’s disease

Mesh:

Year:  2016        PMID: 27515029     DOI: 10.1007/s00702-016-1603-9

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  209 in total

1.  Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial.

Authors:  William J Marks; Raymond T Bartus; Joao Siffert; Charles S Davis; Andres Lozano; Nicholas Boulis; Jerrold Vitek; Mark Stacy; Dennis Turner; Leonard Verhagen; Roy Bakay; Raymond Watts; Barton Guthrie; Joseph Jankovic; Richard Simpson; Michele Tagliati; Ron Alterman; Matthew Stern; Gordon Baltuch; Philip A Starr; Paul S Larson; Jill L Ostrem; John Nutt; Karl Kieburtz; Jeffrey H Kordower; C Warren Olanow
Journal:  Lancet Neurol       Date:  2010-10-20       Impact factor: 44.182

2.  Long-term evaluation of a phase 1 study of AADC gene therapy for Parkinson's disease.

Authors:  Gabriele Mittermeyer; Chadwick W Christine; Kathryn H Rosenbluth; Suzanne L Baker; Philip Starr; Paul Larson; Paul L Kaplan; John Forsayeth; Michael J Aminoff; Krystof S Bankiewicz
Journal:  Hum Gene Ther       Date:  2012-04-10       Impact factor: 5.695

3.  Tai Chi training is effective in reducing balance impairments and falls in patients with Parkinson's disease.

Authors:  William W N Tsang
Journal:  J Physiother       Date:  2013-03       Impact factor: 7.000

Review 4.  The beneficial role of intensive exercise on Parkinson disease progression.

Authors:  Giuseppe Frazzitta; Pietro Balbi; Roberto Maestri; Gabriella Bertotti; Natalia Boveri; Gianni Pezzoli
Journal:  Am J Phys Med Rehabil       Date:  2013-06       Impact factor: 2.159

5.  Vitamin D from different sources is inversely associated with Parkinson disease.

Authors:  Liyong Wang; Marian L Evatt; Lizmarie G Maldonado; William R Perry; James C Ritchie; Gary W Beecham; Eden R Martin; Jonathan L Haines; Margaret A Pericak-Vance; Jeffery M Vance; William K Scott
Journal:  Mov Disord       Date:  2014-12-27       Impact factor: 10.338

Review 6.  Caffeine as a lead compound for the design of therapeutic agents for the treatment of Parkinson's disease.

Authors:  Jacobus P Petzer; Anel Petzer
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

7.  Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson's disease.

Authors:  Neelam K Venkataramana; Satish K V Kumar; Sudheer Balaraju; Radhika Chemmangattu Radhakrishnan; Abhilash Bansal; Ashish Dixit; Deepthi K Rao; Madhulita Das; Majahar Jan; Pawan Kumar Gupta; Satish M Totey
Journal:  Transl Res       Date:  2009-08-06       Impact factor: 7.012

8.  Development of Nonviral Vectors Targeting the Brain as a Therapeutic Approach For Parkinson's Disease and Other Brain Disorders.

Authors:  Hayate Javed; Sindhu A Menon; Karima M Al-Mansoori; Abdelmojib Al-Wandi; Nour K Majbour; Mustafa T Ardah; Shiji Varghese; Nishant N Vaikath; M Emdadul Haque; Mimoun Azzouz; Omar Ma El-Agnaf
Journal:  Mol Ther       Date:  2015-12-24       Impact factor: 11.454

9.  Running rewires the neuronal network of adult-born dentate granule cells.

Authors:  Carmen Vivar; Benjamin D Peterson; Henriette van Praag
Journal:  Neuroimage       Date:  2015-11-14       Impact factor: 6.556

10.  Near-infrared light is neuroprotective in a monkey model of Parkinson disease.

Authors:  Fannie Darlot; Cécile Moro; Nabil El Massri; Claude Chabrol; Daniel M Johnstone; Florian Reinhart; Diane Agay; Napoleon Torres; Dhaïf Bekha; Vincent Auboiroux; Thomas Costecalde; Cassandra L Peoples; Helena D T Anastascio; Victoria E Shaw; Jonathan Stone; John Mitrofanis; Alim-Louis Benabid
Journal:  Ann Neurol       Date:  2015-12-12       Impact factor: 11.274

View more
  5 in total

Review 1.  (Neuro)Psychological Interventions for Non-Motor Symptoms in the Treatment of Patients with Parkinson's Disease: a Systematic Umbrella Review.

Authors:  Hanna Kampling; Lisa K Brendel; Oskar Mittag
Journal:  Neuropsychol Rev       Date:  2019-06-05       Impact factor: 7.444

2.  Dementia-Related Functional Disability in Moderate to Advanced Parkinson's Disease: Assessment Using the World Health Organization Disability Assessment Schedule 2.0.

Authors:  Jia-Hung Chen; Chien-Tai Hong; Dean Wu; Wen-Chou Chi; Chia-Feng Yen; Hua-Fang Liao; Lung Chan; Tsan-Hon Liou
Journal:  Int J Environ Res Public Health       Date:  2019-06-24       Impact factor: 3.390

3.  More Than Movement: Exploring Motor Simulation, Creativity, and Function in Co-developed Dance for Parkinson's.

Authors:  Judith Bek; Aline I Arakaki; Fleur Derbyshire-Fox; Gayathri Ganapathy; Matthew Sullivan; Ellen Poliakoff
Journal:  Front Psychol       Date:  2022-02-28

4.  Evaluation of the Antioxidant and Neuroprotectant Activities of New Asymmetrical 1,3-Diketones.

Authors:  Carla I Nieto; María Pilar Cornago; María Pilar Cabildo; Dionisia Sanz; Rosa M Claramunt; María Carmen Torralba; María Rosario Torres; Diana Martínez Casanova; Yaiza Rebeca Sánchez-Alegre; Esther Escudero; José Luis Lavandera
Journal:  Molecules       Date:  2018-07-24       Impact factor: 4.411

5.  Comparison of efficacy and safety of complementary and alternative therapies for Parkinson's disease: A Bayesian network meta-analysis protocol.

Authors:  Chuancheng Li; Hongqiang An; Jiahao Wang; Zhenyuan Jiang; Tianqi Zhang; Qing Huo
Journal:  Medicine (Baltimore)       Date:  2020-09-18       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.